phenylethyl alcohol has been researched along with Disease Models, Animal in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.76) | 18.2507 |
| 2000's | 31 (23.66) | 29.6817 |
| 2010's | 82 (62.60) | 24.3611 |
| 2020's | 17 (12.98) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Desoky, AA; Elharrif, MG; Elmaksoud, HAA; Ibrahimi, A; Motawea, MH | 1 |
| Gur, C; Ileriturk, M; Kandemir, FM; Kaynar, O; Semis, HS | 1 |
| Anpilogov, K; Beccari, T; Bertelli, M; Bhusan Tripathi, Y; Ceccarini, MR; Cecchin, S; Coatto, M; Dhuli, K; Donato, K; Michelini, S; Mishra, P; Pandey, N; Paolacci, S; Tripathi, P | 1 |
| Cao, Y; Qiu, Z; Song, M; Tian, W; Wang, C; Wang, Q; Xiao, J | 1 |
| Miao, F | 1 |
| Andrieu, P; Cabeza, L; Cramoisy, S; Haffen, E; Houdayer, C; Millot, JL; Peterschmitt, Y; Ramadan, B; Risold, PY | 1 |
| Cañuelo, A; Garcia-Moreno, JC; Martínez-Lara, E; Porta de la Riva, M; Siles, E | 1 |
| Bustamante, A; Echeverría, F; Espinosa, A; Gonzalez-Mañán, D; Illesca, P; Orellana, P; Ortiz, M; Soto-Alarcón, SA; Valenzuela, R; Videla, LA | 1 |
| Chernysheva, GA; Khodanovich, MY; Kisel', AA; Krutenkova, EP; Kudabaeva, MS; Plotnikov, MB; Smol'yakova, VI; Tyumentseva, YА | 1 |
| He, W; Huang, Y; Li, M; Li, W; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Aksu Kızıldağ, C; Albayrak, M; Arabacı, T; Balseven, HM; Kızıldağ, A; Tasdemir, U | 1 |
| Alrais, M; Blackwell, SC; Facchinetti, F; Liu, C; Longo, M; Menichini, D; Sibai, BM; Xia, Y | 1 |
| Akcay, E; Palaz, MN | 1 |
| Brunetti, G; Calabrese, V; Di Rosa, G; Leri, M; Saul, N; Schmitz-Linneweber, C; Scuto, M; Stefani, M | 1 |
| Cantürk Tan, F; Ceylan, T; Kaymak, E; Yakan, B | 1 |
| Chen, Y; Fang, Q; Jiang, DS; Zhang, Y | 1 |
| Cao, Y; Du, Q; Jiang, Y; Jiao, X; Li, Y; Liu, X; Tang, M; Tian, C; Wang, Y; Wang, Z; Xie, P; Yang, J | 1 |
| Hu, C; Liu, Y; Shen, L; Yin, H; Zeng, J; Zhang, K; Zhang, L; Zhao, YT; Zheng, W | 1 |
| Cellat, M; Dikmen, N; Etyemez, M; Gökçek, İ; Güvenç, M; İşler, CT; Kuzu, M; Türk, E; Uyar, A | 1 |
| Amiot, MJ; Peyrol, J; Riva, C | 1 |
| Dokuyucu, R; Gökçe, H; Gülmez, Mİ; Okuyucu, Ş | 1 |
| He, Y; Jing, T; Li, Y; Lin, R; Wang, B; Wang, W; Wei, J; Xiao, Y; Yang, X; Zhang, J; Zhang, W | 1 |
| Chen, S; Deng, W; Li, J; Liao, H; Ren, J; Tang, Q; Xu, L; Yang, Z; Zhang, N | 1 |
| Kırzıoğlu, FY; Nazıroğlu, M; Özmen, Ö; Uğuz, AC; Yiğit, U | 1 |
| Khan, MN; Lane, ME; McCarron, PA; Tambuwala, MM | 1 |
| Deveci, HA; Karapehlivan, M | 1 |
| Cara, FE; El-Azem, N; Granados-Principal, S; Pulido-Moran, M; Quiles, JL; Ramirez-Tortosa, CL; Ramirez-Tortosa, M; Sanchez-Rovira, P | 1 |
| Hang, C; Liao, K; Sun, L | 1 |
| Casamenti, F; Lapucci, A; Nardiello, P; Pantano, D; Stefani, M | 1 |
| Agüera, E; Aguilar-Luque, M; Conde, C; Escribano, BM; Feijóo, M; Giraldo, AI; LaTorre, M; Lillo, R; Luque, E; Ochoa, JJ; Santamaría, A; Túnez, I | 1 |
| Aliev, OI; Anishchenko, AM; Arkhipov, AM; Fomina, TI; Plotnikov, MB; Plotnikova, TM; Shamanaev, AY; Sidekhmenova, AV | 1 |
| Balkhi, HM; Gul, T; Haq, E; Sana, S | 1 |
| de Roos, B; Duthie, GG; Fernández-Bolaños, J; Gómez-Carretero, A; Maya, I; Rodríguez-Gutiérrez, G; Rubio-Senent, F | 1 |
| Dos Santos, JS; Monte-Alto-Costa, A; Romana-Souza, B | 1 |
| ArunSundar, M; Ravichandiran, V; Shanmugarajan, TS | 1 |
| Dhammu, TS; Khan, H; Khan, M; Shunmugavel, A; Singh, AK; Singh, I | 1 |
| Kesharwani, P; McCarron, PA; Shukla, R; Tambuwala, MM; Thompson, PD | 1 |
| Khan, MN; McCarron, PA; Tambuwala, MM; Thompson, P | 1 |
| Fabiani, R; Fuccelli, R; Rosignoli, P | 1 |
| Cheng, CC; Chi, PL; Huang, WC; Liu, CP; Shen, MC; Shu, CW; Tseng, CJ; Wann, SR | 1 |
| Chen, C; Huang, L; Jia, Y; Jiang, S; Lu, G; Sun, X; Xie, Y | 1 |
| Arai, T; Araki, W; Araki, YM; Itoh, M; Kametani, F; Mamada, N; Mizusawa, H; Saitoh, A; Sakai, Y; Sekiguchi, M; Tamaoka, A; Taniguchi, K; Wada, K; Yamada, D; Yamamoto, F; Yang, J | 1 |
| Astiz, S; Encinas, T; Garcia-Contreras, C; Gonzalez-Bulnes, A; Heras-Molina, A; Isabel, B; Nieto, R; Ovilo, C; Pardo, Z; Torres-Rovira, L; Vazquez-Gomez, M | 1 |
| Akdemir, F; Evliyaoglu, O; Evsen, MS; Ozler, A; Sak, ME; Soydinc, HE; Turgut, A; Turkcu, G | 1 |
| Bai, H; Chen, H; Hai, C; Li, W; Liang, X; Liu, R; Qin, X; Wang, X; Zhang, W; Zhang, X | 1 |
| Jiang, H; Kang, K; Liu, L; Ma, Y; Pan, H; Pan, S; Sun, B; Sun, X; Wang, D; Wang, J | 1 |
| Hong, S; Jung, Y; Kim, H; Kim, W; Kwak, MK; Lee, JW; Na, DH; Oh, JE; Park, EJ; Yum, S | 1 |
| Guan, S; Huang, G; Lu, J; Song, B; Wang, Z; Xiong, Y; Xu, L; Zhuang, S | 1 |
| Bayram, E; Karakaya, P; Kurul, SH; Özbal, S; Topçu, Y; Tuğyan, K; Yilmaz, O; Yiş, U | 1 |
| Aşçı, M; Bostan, B; Erdem, M; Gülabi, D; Güneş, T; Köseoğlu, RD | 1 |
| İlhan, S; Motor, S; Nacar, E; Oktar, S; Şahna, E; Yılmaz, N | 1 |
| Akyol, O; Akyol, S; Balci, M; Cakmak, O; Erden, G; Gurel, A; Ugurcu, V | 1 |
| Arunsundar, M; Ravichandran, V; Shanmugarajan, TS | 1 |
| Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC | 1 |
| Bae, ON; Bae, S; Kim, ES; Koo, JE; Lee, JY; Lim, KM | 1 |
| de Roos, B; Duthie, G; Fernández-Bolaños, J; Rodríguez-Gutiérrez, G; Rubio-Senent, F | 1 |
| Brites, D; Bronze, MR; Direito, R; Fernandes, A; Fernandes, E; Figueira, ME; Freitas, M; Rocha, J; Sepodes, B; Silva, S | 1 |
| Choi, JH; Ha, SM; Jung, SY; Kang, MS; Lee, JH; Oh, H; Park, S; Park, SJ; Roh, KH; Song, H; Yang, JW | 1 |
| Cantley, MD; Crotti, TN; Dharmapatni, AA; Gibson, RJ; Haynes, DR; Marino, V; Perilli, E; Stansborough, RL; Xu, J; Zawawi, MS | 1 |
| Alici, O; Alici, S; Altintas, ND; Aydin, M; Kavakli, HS; Koca, C | 1 |
| Alp, H; Evliyaoglu, O; Firat, U; Gelincik, I; Kapan, M; Onder, A; Senol, S; Tekin, R; Tokgoz, O | 1 |
| Chen, RC; Fan, W; Liu, ZH | 1 |
| Akyol, O; Akyol, S; Armutcu, F; Erdemli, HK | 1 |
| Guo, L; Li, Y; Shi, L; Shi, Y; Song, M; Yu, J | 1 |
| Cai, XM; Chen, J; Gong, JB; Pei, YH; Wang, X; Xie, L; Yang, RH | 1 |
| Calignano, A; Canani, RB; Di Guida, F; Lama, A; Magliocca, S; Meli, R; Mollica, MP; Paciello, O; Pagano, TB; Pirozzi, C; Raso, GM; Russo, R; Simeoli, R | 1 |
| Naidu, KA; Reddy, KVK | 1 |
| Bastlund, JF; Becker, R; Didriksen, M; Gass, N; Meyer-Lindenberg, A; Sartorius, A; Schwarz, AJ; Stensbøl, TB; Weber-Fahr, W | 1 |
| Baykal, B; Elbey, B; Keskin, I; Kuş, S; Şahin, A; Yazgan, ÜC; Yılmaz, A | 1 |
| Hou, C; Jia, L; Li, C; Li, Y; Liu, J; Long, J; Peng, Y; Shi, L; Tang, Y; Yang, Z | 1 |
| Abadie, J; Beck, L; Gauthier, O; Guicheux, J; Hivernaud, V; Houard, X; Krisa, S; Lesoeur, J; Masson, M; Merceron, C; Mével, E; Nourissat, G; Richard, T; Urban, N; Vinatier, C; Wittrant, Y | 1 |
| Acquaviva, R; Di Giacomo, C; Pittalà, V; Romeo, G; Salerno, L; Sorrenti, V | 1 |
| Choi, JY; Jeong, S; Jung, Y; Kim, ND; Lee, HE; Lee, JY; Park, HH; Yang, G | 1 |
| Andreadou, I; Brown, L; Efentakis, P; Gikas, E; Halabalaki, M; Lemonakis, N; Poudyal, H; Skaltsounis, L | 1 |
| Brown, L; Gikas, E; Halabalaki, M; Lemonakis, N; Poudyal, H; Skaltsounis, AL; Tsarbopoulos, A | 1 |
| Abdullah, HI; Durdagi, S; Duruyurek, M; Ekhteiari Salmas, R; Gulhan, MF; Selamoglu, Z | 1 |
| Agalias, A; Coxam, V; Davicco, MJ; Horcajada, MN; Lebecque, P; Mardon, J; Mazur, A; Puel, C; Skaltsounis, AL | 1 |
| Maulik, N; Paul, D; Penumathsa, SV; Samuel, SM; Thirunavukkarasu, M | 1 |
| Hennig, B; MacDonald, R; Oesterling, E; Shen, H; Stromberg, A; Toborek, M | 1 |
| Ciçek, E; Gökalp, O; Ozçelik, N; Ozer, MK; Uz, E; Yilmaz, HR | 1 |
| Battino, M; Bullon, P; Goteri, G; Granados-Principal, S; Morillo, JM; Quiles, JL; Ramirez-Tortosa, M; Rubini, C | 1 |
| Bagci, C; Bilgic, T; Buyukberber, M; Ceylan, NO; Gulsen, MT; Koruk, M; Savaş, MC; Tutar, E | 1 |
| Aydin, M; Davarci, M; Gökçe, A; Ilhan, S; Oktar, S; Ozkan, OV; Yalçinkaya, FR; Yönden, Z | 1 |
| Brown, L; Campbell, F; Poudyal, H | 1 |
| Ateş, B; Erdoğan, A; Eşrefoğlu, M; Gül, M | 1 |
| Gomonchareonsiri, S; Thamprasert, K; Wongmekiat, O | 1 |
| Aliev, OI; Chernyshova, GA; Krasnov, EA; Plotnikov, MB; Smol'iakova, VI | 1 |
| Andiran, F; Haltas, H; Hirfanoglu, IM; Kosus, A; Tatli, MM; Tayman, C; Tonbul, A; Uysal, S | 1 |
| Bordignon-Luiz, MT; Ferreira, EA; Filho, DW; Gris, EF; Mattivi, F; Pedrosa, RC; Vrhovsek, U | 1 |
| de la Torre, R; Hinojosa, AJ; Pontes, AJ; Tasset, I; Túnez, I | 1 |
| Cherif, M; Elgaaied, AB; Hamden, K; Hamrita, B; Jaouadi, B; Kouidi, S; Medimegh, I; Messai, Y; Ouerhani, S; Rouissi, K | 1 |
| Alarcón de la Lastra, C; Cárdeno, A; Sánchez de Ibargüen, L; Sánchez-Fidalgo, S | 1 |
| Feng, SF; Li, XQ; Liu, SB; Shi, TY; Tian, Z; Wu, YM; Xing, JH; Zhang, N; Zhao, MG | 1 |
| Dash, PK; Moore, AN; Pati, S; Redell, JB; Zhang, M; Zhao, J | 1 |
| Du, Y; Farlow, MR; Fontanilla, CV; Johnstone, B; Pascuzzi, RM; Wei, X; Zhao, L | 1 |
| Hisatsune, A; Isohama, Y; Katsuki, H; Kurauchi, Y; Mishima, S | 1 |
| Beltrán-Ramírez, O; Pérez, RM; Sierra-Santoyo, A; Villa-Treviño, S | 1 |
| Cantlay, LL; de Roos, B; Duthie, GG; Fernández-Bolaños Guzmán, J; Horgan, GW; Kelder, T; Morrice, P; Nicol, F; Reid, M; Rodríguez-Gutiérrez, G; Wood, S | 1 |
| Carvalho, LR; Castiglia, YM; Correa, RR; de Oliveira, CC; de Souza, AV; Roso, NC; Scatena, LM; Vianna, PT | 1 |
| Atar, M; Bodakcı, MN; Bozkurt, M; Bozkurt, Y; Hatipoglu, NK; Kıbrıslı, E; Penbegul, N; Sancaktutar, AA; Soylemez, H; Turkçu, G; Yavuz, C; Yuksel, H | 1 |
| Agackıran, Y; Atik, D; Delibas, N; Ginis, Z; Koylu, H; Sırmalı, M; Sırmalı, R; Solak, O; Tezel, C | 1 |
| Akoglu, M; Bostanci, EB; Duzcan, SE; Kelten, EC; Sacar, S; Simsek, NG; Teke, Z; Yenisey, C | 1 |
| Choi, J; Jeong, E; Kim, SY; Koo, JE; Lee, JY; Lim, KM; Park, ZY; Seo, YJ; Tyagi, N | 1 |
| Baffa, O; Barbosa, F; Barros Silva, R; Del-Bel, E; Ferreira, DA; Kinoshita, A; Martins, NM; Oliveira Souza, VC; Santos, AC; Santos, NA | 1 |
| Buang, F; Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC; Sahudin, S | 1 |
| Akyol, O; Güleç, M; Ozyurt, H; Sahin, S; Söğüt, S; Uz, E; Var, A | 1 |
| Ayan, I; Bora, A; Elmali, N; Germen, B; Mizrak, B; Türköz, Y | 1 |
| Bockaert, J; Briant, L; Courseau, AS; de Bock, F; Lerner-Natoli, M; Montpied, P; Niel, G; Rondouin, G | 1 |
| Burke, WJ; Li, SW; Nonneman, R; Williams, EA; Zahm, DS | 1 |
| Arce-Popoca, E; Carrasco-Legleu, CE; Fattel-Fazenda, S; Márquez-Rosado, L; Pérez-Carreón, JI; Villa-Treviño, S | 1 |
| Akyol, O; Armutcu, F; Gurel, A; Ilhan, A; Iraz, M; Oztas, E | 1 |
| Akyol, O; Gulec, M; Iraz, M; Kalcioglu, MT; Kizilay, A; Ozerol, E; Ozturan, O | 1 |
| Altinyazar, C; Armutcu, F; Gurel, A; Hosnuter, M; Kargi, E; Unalacak, M | 1 |
| Nishioka, N; Tsuji, T; Yoshizumi, K | 1 |
| Atik, U; Cinel, L; Değirmenci, U; Kanik, A; Oz, O; Tamer, L; Vatansever, H; Yildirim, O; Yilmaz, A | 1 |
| Akyol, O; Bagci, C; Cagli, K; Cavdar, S; Cengiz, B; Dinckan, H; Gulec, M; Pence, S; Sari, I | 1 |
| Chih, CL; Huang, SS; Liao, PH; Lin, MJ; Lin, RH; Lin, SM; Liu, SM; Tsai, SK; Yang, CY | 1 |
| Erdogan, S; Fadillioglu, E; Iraz, M; Tasdemir, S | 1 |
| Agalias, A; Coxam, V; Davicco, MJ; Horcajada, MN; Kati-Coulibaly, S; Lebecque, P; Mardon, J; Obled, C; Puel, C; Rock, E; Skaltsounis, LA | 1 |
| Ansari, MA; Elango, C; Khan, M; Singh, AK; Singh, I | 1 |
| Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
| Güney, M; Karahan, N; Mungan, T; Nasir, S; Oral, B | 1 |
| Choi, I; Choi, IW; Choi, YH; Jung, WK; Kang, MS; Kim, SK; Lee, DY; Lee, SW; Park, SG; Seo, SK; Yea, SS | 1 |
| Altuğ, E; Atik, E; Avci, G; Kontas, T; Serarslan, G | 1 |
| Alhan, E; Ates, B; Ercin, C; Erdogan, S; Kaklikkaya, N; Kural Vanizor, B; Topaloglu, S; Turkyilmaz, S | 1 |
| Abrahamyan, H; Gabrielyan, E; Hovhannisyan, A; Nikoyan, N; Ohanyan, N; Panossian, A; Wikman, G | 1 |
| Capasso, G; Ciarcia, R; Damiano, S; Della Ragione, F; Di Gennaro, CI; Florio, S; Galletti, P; Manna, C; Mazzoni, O; Perna, A; Pollastro, RM; Zappia, V | 1 |
| Choi, I; Choi, IW; Choi, YH; Jeon, YJ; Jung, WK; Kim, SK; Lee, CM; Lee, DY; Lee, SW; Park, SG; Seo, SK; Yea, SS | 1 |
| Akyol, O; Ciralik, H; Ilhan, A; Koltuksuz, U; Ozen, S; Uz, E | 1 |
| Fitzpatrick, LR; Le, T; Wang, J | 1 |
3 review(s) available for phenylethyl alcohol and Disease Models, Animal
| Article | Year |
|---|---|
Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders.
Topics: Adiposity; Animals; Antioxidants; Body Weight; Diet, Mediterranean; Disease Models, Animal; Homeostasis; Humans; Hyperglycemia; Lipid Metabolism; Metabolic Syndrome; Olive Oil; Oxidative Stress; Phenylethyl Alcohol; Polyphenols | 2017 |
Caffeic acid phenethyl ester: its protective role against certain major eye diseases.
Topics: Animals; Bees; Caffeic Acids; Disease Models, Animal; Eye Diseases; Humans; NF-kappa B; Phenylethyl Alcohol; Propolis | 2014 |
Therapeutic Potential of Caffeic Acid Phenethyl Ester (CAPE) in Diabetes.
Topics: Animals; Antioxidants; Caffeic Acids; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Humans; Oxidative Stress; Phenylethyl Alcohol; Polyphenols | 2018 |
128 other study(ies) available for phenylethyl alcohol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Hydroxytyrosol alleviate intestinal inflammation, oxidative stress and apoptosis resulted in ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Colitis, Ulcerative; Cytokines; Disease Models, Animal; Inflammation; Male; Olea; Oxidative Stress; Phenylethyl Alcohol; Plant Extracts; Rats | 2021 |
Investigation of the anti-inflammatory effects of caffeic acid phenethyl ester in a model of λ-Carrageenan-induced paw edema in rats.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Carrageenan; Disease Models, Animal; Edema; Male; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2021 |
Effect of a dietary supplement on the reduction of lymphedema-progression in mouse tail-cut model.
Topics: Animals; Citrus; Dietary Supplements; Disease Models, Animal; Disease Progression; Lymphedema; Mice; Olea; Oryza; Phenylethyl Alcohol; Plant Extracts; Tail; Treatment Outcome; Vitamin A; Wound Healing | 2021 |
Hydroxytyrosol Alleviates Dextran Sulfate Sodium-Induced Colitis by Modulating Inflammatory Responses, Intestinal Barrier, and Microbiome.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Phenylethyl Alcohol | 2022 |
Hydroxytyrosol alleviates dextran sodium sulfate-induced colitis by inhibiting NLRP3 inflammasome activation and modulating gut microbiota in vivo.
Topics: Animals; Antioxidants; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammasomes; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylethyl Alcohol; Sulfates | 2022 |
Beneficial effects of prolonged 2-phenylethyl alcohol inhalation on chronic distress-induced anxio-depressive-like phenotype in female mice.
Topics: Animals; Anxiety; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Female; Hypothalamo-Hypophyseal System; Mice; Phenotype; Phenylethyl Alcohol; Pituitary-Adrenal System | 2022 |
Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antioxidants; Caenorhabditis elegans; Dietary Supplements; Disease Models, Animal; Drug Delivery Systems; Nerve Degeneration; Olive Oil; Parkinsonian Disorders; Phenylethyl Alcohol | 2019 |
Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approach.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Docosahexaenoic Acids; Drug Synergism; Fatty Liver; Humans; Inflammation; Lipid Metabolism; Liver; Mice; Oxidative Stress; Phenylethyl Alcohol; PPAR alpha | 2019 |
p-Tyrosol Enhances the Production of New Neurons in the Hippocampal CA1 Field after Transient Global Cerebral Ischemia in Rats.
Topics: Animals; CA1 Region, Hippocampal; Disease Models, Animal; Doublecortin Protein; Ischemic Attack, Transient; Male; Nerve Regeneration; Neurogenesis; Neurons; Neuroprotective Agents; Phenylethyl Alcohol; Rats; Rats, Wistar | 2019 |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling.
Topics: Alzheimer Disease; Animals; Apoptosis; Caffeic Acids; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Heme Oxygenase-1; Humans; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats; RNA, Small Interfering; Scopolamine; Signal Transduction | 2019 |
A biochemical and immunohistochemical study of the effects of caffeic acid phenethyl ester on alveolar bone loss and oxidative stress in diabetic rats with experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Oxidative Stress; Periodontitis; Phenylethyl Alcohol; Rats, Wistar; Streptozocin | 2020 |
Maternal Supplementation of Inositols, Fucoxanthin, and Hydroxytyrosol in Pregnant Murine Models of Hypertension.
Topics: Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Hypertension; Inositol; Mice; Mice, Knockout; Phenylethyl Alcohol; Pregnancy; Random Allocation; Xanthophylls | 2020 |
The Impact of Propolis Factor Caffeic Acid Phenethyl-Ester on the Cerebral Vasospasm and Early Brain Damage in the Experimentally Induced Subarachnoid Hemorrhage on Rats.
Topics: Animals; CA3 Region, Hippocampal; Caffeic Acids; Disease Models, Animal; Neurons; Neuroprotective Agents; Phenylethyl Alcohol; Propolis; Rats, Wistar; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2020 |
Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in
Topics: Acetates; alpha-Synuclein; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cyclopentane Monoterpenes; Disease Models, Animal; Dopaminergic Neurons; Parkinson Disease; Phenylethyl Alcohol; Polyphenols; Pyrans; Treatment Outcome | 2020 |
Research on the protective effect of caffeic acid phenethyl ester on testicular damage caused by cisplatin
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cisplatin; Disease Models, Animal; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Testicular Diseases; Testis | 2020 |
Hydroxytyrosol inhibits apoptosis in ischemia/reperfusion-induced acute kidney injury via activating Sonic Hedgehog signaling pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Survival; Cells, Cultured; Disease Models, Animal; Hedgehog Proteins; Humans; Male; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2020 |
Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Binding Sites; Caffeic Acids; Carcinoma, Hepatocellular; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Liver Neoplasms; Male; Mice; Molecular Docking Simulation; Phenylethyl Alcohol; src-Family Kinases; Structure-Activity Relationship | 2021 |
Hydroxytyrosol alleviates oxidative stress and neuroinflammation and enhances hippocampal neurotrophic signaling to improve stress-induced depressive behaviors in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cytokines; Depression; Disease Models, Animal; Hindlimb Suspension; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Phenylethyl Alcohol; Signal Transduction; Stress, Psychological; Swimming | 2021 |
Tyrosol improves ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Catalase; Cytokines; Disease Models, Animal; Eosinophils; Glutathione; Glutathione Peroxidase; Immunoglobulin E; Leukocyte Count; Lung; NF-kappa B; Ovalbumin; Phenylethyl Alcohol; Rats, Wistar | 2021 |
The effect of caffeic acid phenethyl ester and thymoquinone on otitis media with effusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Caffeic Acids; Disease Models, Animal; Eustachian Tube; Injections, Intraperitoneal; Male; Otitis Media with Effusion; Phenylethyl Alcohol; Rats; Rats, Wistar; Temporal Bone | 2017 |
Hydroxytyrosol Attenuates LPS-Induced Acute Lung Injury in Mice by Regulating Autophagy and Sirtuin Expression.
Topics: Acute Lung Injury; Animals; Autophagy; Capillary Permeability; Chemokines; Cytokines; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Mice; Models, Molecular; Molecular Conformation; Phenylethyl Alcohol; Sirtuins | 2017 |
Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
Topics: Animals; Blotting, Western; Caffeic Acids; Cardiomegaly; Cell Line; Disease Models, Animal; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Phenylephrine; Phenylethyl Alcohol; Polymerase Chain Reaction; Rats; Resveratrol; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2017 |
Is caffeic acid phenethyl ester more protective than doxycycline in experimental periodontitis?
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Caffeic Acids; Cytokines; Disease Models, Animal; Doxycycline; Enzyme-Linked Immunosorbent Assay; Lipid Peroxidation; Male; Oxidants; Oxidative Stress; Periodontitis; Phenylethyl Alcohol; Rats; Rats, Wistar | 2017 |
Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Female; Inflammation; Inflammation Mediators; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Protective Agents | 2018 |
Chlorpyrifos-induced parkinsonian model in mice: Behavior, histopathology and biochemistry.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Brain; Caffeic Acids; Chlorpyrifos; Disease Models, Animal; Insecticides; Lipid Metabolism; Male; Mice; Motor Activity; N-Acetylneuraminic Acid; Neuroprotective Agents; Parkinsonian Disorders; Phenylethyl Alcohol | 2018 |
Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Oxidative Stress; Paclitaxel; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Burden | 2019 |
Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Caffeic Acids; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Microbial Sensitivity Tests; Phenylethyl Alcohol | 2018 |
Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloidosis, Familial; Animals; Antioxidants; Autophagy; Brain; Cognition Disorders; Corneal Dystrophies, Hereditary; Diet; Disease Models, Animal; Glial Fibrillary Acidic Protein; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenylethyl Alcohol; Presenilin-1; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat.
Topics: Animals; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Male; Multiple Sclerosis; Oleic Acid; Olive Oil; Phenylethyl Alcohol; Rats; Spinal Cord | 2020 |
Effect of p-tyrosol on hemorheological parameters and cerebral capillary network in young spontaneously hypertensive rats.
Topics: Age Factors; Animals; Arterial Pressure; Blood Viscosity; Capillaries; Cerebral Cortex; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Hemorheology; Hypertension; Microcirculation; Neovascularization, Physiologic; Phenylethyl Alcohol; Rats, Inbred SHR; Rats, Inbred WKY | 2018 |
Anti-glioma Effects of Caffeic Acid Phenethyl Ester and Dasatinib Combination Therapy in an in vivo Rat Glioma Model.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cell Proliferation; Dasatinib; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Glioma; Male; Molecular Structure; Phenylethyl Alcohol; Rats; Rats, Wistar; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Selenium and sulphur derivatives of hydroxytyrosol: inhibition of lipid peroxidation in liver microsomes of vitamin E-deficient rats.
Topics: Animals; Disease Models, Animal; Lipid Peroxidation; Microsomes, Liver; Phenylethyl Alcohol; Rats; Selenium; Sulfur; Vitamin E Deficiency | 2019 |
Caffeic acid phenethyl ester promotes wound healing of mice pressure ulcers affecting NF-κB, NOS2 and NRF2 expression.
Topics: Animals; Caffeic Acids; Disease Models, Animal; Gene Expression Regulation; Inflammation; Lipid Peroxidation; Male; Mice; NF-E2-Related Factor 2; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Oxidative Stress; Phenylethyl Alcohol; Pressure Ulcer; Reactive Oxygen Species; Reperfusion Injury; Skin; Wound Healing | 2018 |
3,4-Dihydroxyphenylethanol Assuages Cognitive Impulsivity in Alzheimer's Disease by Attuning HPA-Axis via Differential Crosstalk of α7 nAChR with MicroRNA-124 and HDAC6.
Topics: alpha Karyopherins; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Antioxidants; Corticosterone; Decision Making; Disease Models, Animal; Epigenesis, Genetic; Hippocampus; Histone Deacetylase 6; HSP90 Heat-Shock Proteins; Hypothalamo-Hypophyseal System; Impulsive Behavior; Mice; MicroRNAs; Phenylethyl Alcohol; Pituitary-Adrenal System; Receptors, Glucocorticoid | 2018 |
Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.
Topics: Amino Acid Oxidoreductases; AMP-Activated Protein Kinases; Animals; Antioxidants; Behavior Rating Scale; Brain Injuries, Traumatic; Caffeic Acids; Disease Models, Animal; Drug Synergism; Dynamins; GTP Phosphohydrolases; Heme Oxygenase-1; Membrane Proteins; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Neurons; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylethyl Alcohol; Protein Serine-Threonine Kinases; S-Nitrosoglutathione; Superoxide Dismutase | 2018 |
Caffeic acid phenethyl ester (CAPE) reverses fibrosis caused by chronic colon inflammation in murine model of colitis.
Topics: Animals; Caffeic Acids; Colitis; Colon; Disease Models, Animal; Female; Fibrosis; Inflammation; Mice; Mice, Inbred C57BL; Phenylethyl Alcohol | 2018 |
Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.
Topics: Albumins; Animals; Biological Availability; Caffeic Acids; Colitis; Dextran Sulfate; Disease Models, Animal; Drug Combinations; Drug Compounding; Drug Synergism; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Nanoparticles; Particle Size; Phenylethyl Alcohol; Signal Transduction; Stilbenes; Transcription Factor RelA | 2019 |
Hydroxytyrosol Exerts Anti-Inflammatory and Anti-Oxidant Activities in a Mouse Model of Systemic Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cyclooxygenase 2; Cytokines; Disease Models, Animal; DNA Damage; Inflammation; Lipopolysaccharides; Mice; Oxidation-Reduction; Oxidative Stress; Phenylethyl Alcohol; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
Topics: Animals; Apoptosis; Caffeic Acids; Cell Line; Cell Proliferation; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Phenylethyl Alcohol; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Signal Transduction; Vascular Remodeling | 2019 |
Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death.
Topics: Animals; Astrocytes; Caffeic Acids; Cell Death; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Chemokine CCL2; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Ependymoglial Cells; Glaucoma; Gliosis; In Situ Nick-End Labeling; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase Type II; Optic Nerve Injuries; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Signal Transduction; Transcription Factor Brn-3A; Tumor Necrosis Factor-alpha | 2019 |
Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Caspase 3; Cells, Cultured; Cognitive Dysfunction; Disease Models, Animal; Humans; Mice; Microfilament Proteins; Nerve Tissue Proteins; Neurons; Neurotoxins; Oxidative Stress; Phenylethyl Alcohol; Plant Extracts; Rhodiola | 2019 |
Polyphenols and IUGR Pregnancies: Effects of Maternal Hydroxytyrosol Supplementation on Hepatic Fat Accretion and Energy and Fatty Acids Profile of Fetal Tissues.
Topics: Adiposity; Animals; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Fatty Acids; Female; Fetal Growth Retardation; Fetus; Lipid Peroxidation; Liver; Maternal Exposure; Muscle, Skeletal; Phenylethyl Alcohol; Pregnancy; Sus scrofa | 2019 |
Effect of caffeic acid phenethyl ester on intra-abdominal adhesion in rats.
Topics: Abdominal Cavity; Animals; Anti-Inflammatory Agents; Antioxidants; Caffeic Acids; Disease Models, Animal; Female; Infusions, Parenteral; Laparotomy; Phenylethyl Alcohol; Rats; Tissue Adhesions; Uterus | 2013 |
Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Bleomycin; Caffeic Acids; Cell Survival; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Gene Silencing; Hydroxyproline; Intubation, Intratracheal; Lipid Peroxidation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Oxidoreductases; Phenylethyl Alcohol; Pulmonary Fibrosis; Reactive Oxygen Species | 2013 |
Protective effects of hydroxytyrosol on liver ischemia/reperfusion injury in mice.
Topics: Animals; Antioxidants; Apoptosis; Catalase; Cell Survival; Chemokine CXCL2; Disease Models, Animal; Hepatocytes; In Situ Nick-End Labeling; Interleukin-6; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Oxidative Stress; Phenylethyl Alcohol; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2013 |
Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Caffeic Acids; Cell Line, Tumor; Chromatography, High Pressure Liquid; Colitis; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; NF-E2-Related Factor 2; Oxidative Stress; Phenylethyl Alcohol; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Structure-Activity Relationship | 2013 |
Tyrosol exhibits negative regulatory effects on LPS response and endotoxemia.
Topics: Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Endotoxemia; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Phenylethyl Alcohol; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Caffeic acid phenethyl ester prevents apoptotic cell death in the developing rat brain after pentylenetetrazole-induced status epilepticus.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Brain; Caffeic Acids; Caspase 3; Convulsants; Disease Models, Animal; In Situ Nick-End Labeling; Male; Neurons; Neuroprotective Agents; Pentylenetetrazole; Phenylethyl Alcohol; Rats; Rats, Wistar; Status Epilepticus | 2013 |
The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Fracture Fixation, Intramedullary; Fracture Healing; Ischemia; Male; Melatonin; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Wistar; Tibial Fractures | 2014 |
The effect of caffeic acid phenethyl ester on isoproterenol-induced myocardial injury in hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Caffeic Acids; Disease Models, Animal; Hypertension; Injections, Intraperitoneal; Isoproterenol; Lipid Peroxidation; Myocardial Infarction; Phenylethyl Alcohol; Rats | 2014 |
3,4-dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer's disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Survival; Cognition Disorders; Disease Models, Animal; Hippocampus; Ibotenic Acid; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neurons; Neuroprotective Agents; Peptide Fragments; Phenylethyl Alcohol; Signal Transduction | 2015 |
Efficient immuno-modulation of TH1/TH2 biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarrier-mediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Dinoprostone; Disease Models, Animal; Drug Carriers; Histamine; Hydrocortisone; Immunoglobulin E; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Th1 Cells; Th2 Cells; Vascular Endothelial Growth Factor A | 2014 |
Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester.
Topics: Acute Disease; Animals; Caffeic Acids; Cell Line; Chronic Disease; Cyclooxygenase 2; Dermatitis, Atopic; Disease Models, Animal; Humans; Immunoglobulin E; Inflammation; Keratinocytes; Mice; Mice, Inbred Strains; NF-kappa B; Oxazolone; Phenylethyl Alcohol; Propolis; Skin; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Water Loss, Insensible | 2015 |
Inhibitory and synergistic effects of natural olive phenols on human platelet aggregation and lipid peroxidation of microsomes from vitamin E-deficient rats.
Topics: Adult; Animals; Antioxidants; Disease Models, Animal; Female; Humans; Lipid Peroxidation; Male; Methoxyhydroxyphenylglycol; Microsomes; Middle Aged; Olea; Olive Oil; Phenols; Phenylethyl Alcohol; Plant Extracts; Platelet Aggregation; Rats; Vitamin E; Vitamin E Deficiency | 2015 |
Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis, Rheumatoid; Cyclooxygenase 2; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Inflammation; Male; Neutrophils; Nitric Oxide Synthase Type II; Olive Oil; Phenylethyl Alcohol; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |
Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Topics: Animals; Autoimmune Diseases; Blotting, Western; Caffeic Acids; Disease Models, Animal; Eye Proteins; Flow Cytometry; Immunoglobulin G; Interferon-gamma; Interleukin-6; Lymphocyte Activation; Mice; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Retinitis; Retinol-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Caffeic acid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis.
Topics: Animals; Bone Resorption; Caffeic Acids; Disease Models, Animal; Female; Mice; Osteolysis; Phenylethyl Alcohol; Polyethylene; Skull; X-Ray Microtomography | 2015 |
Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.
Topics: Animals; Caffeic Acids; Disease Models, Animal; Endothelin-1; Inflammation; Male; Malondialdehyde; Oxidative Stress; Oxygen; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2015 |
The effects of caffeic acid phenethyl ester (CAPE) on bacterial translocation and inflammatory response in an experimental intestinal obstruction model in rats.
Topics: Animals; Anti-Inflammatory Agents; Bacterial Translocation; Caffeic Acids; Disease Models, Animal; Inflammation Mediators; Injections, Intraperitoneal; Intestinal Mucosa; Intestinal Obstruction; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2015 |
3,4-dihydroxyphenylethanol suppresses irradiation-induced pulmonary fibrosis in adult rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Dexamethasone; Disease Models, Animal; Heme Oxygenase-1; Humans; Lung; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Phenylethyl Alcohol; Pulmonary Fibrosis; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley | 2015 |
Comment on 'Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model' by Choi J.H. et al. [Exp. Eye Res. 134 (2015) 53-62].
Topics: Animals; Autoimmune Diseases; Caffeic Acids; Disease Models, Animal; NF-kappa B; Phenylethyl Alcohol; Retinitis; Uveitis | 2015 |
Caffeic Acid Phenethyl Ester inhibit Hepatic Fibrosis by Nitric Oxide Synthase and Cystathionine Gamma-Lyase in Rats.
Topics: Animals; Caffeic Acids; Cystathionine gamma-Lyase; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Hydrogen Sulfide; Immunohistochemistry; Liver; Liver Cirrhosis; Male; Nitric Oxide Synthase Type II; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2015 |
Hydroxytyrosol Protects against Myocardial Ischemia/Reperfusion Injury through a PI3K/Akt-Dependent Mechanism.
Topics: Animals; Apoptosis; Blotting, Western; Disease Models, Animal; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Phenylethyl Alcohol; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats | 2016 |
Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD.
Topics: Animals; Disease Models, Animal; Duodenum; Hepatitis; Male; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Rats | 2016 |
Oleic acid, hydroxytyrosol and n-3 fatty acids collectively modulate colitis through reduction of oxidative stress and IL-8 synthesis; in vitro and in vivo studies.
Topics: Animals; Caco-2 Cells; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Omega-3; Fish Oils; Humans; Interleukin-8; Male; Oleic Acid; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2016 |
An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Brain Mapping; Cholinergic Agents; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 15; Cyclopropanes; Disease Models, Animal; Endophenotypes; Intellectual Disability; Magnetic Resonance Imaging; Male; Mice, Transgenic; Neural Pathways; Phenylethyl Alcohol; Rest; Schizophrenia; Seizures | 2016 |
Effect of caffeic acid phenethyl ester on oxidant and anti-oxidant status of liver and serum in a rat model with acute methanol intoxication.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Ethanol; Liver; Male; Methanol; Methotrexate; Oxidants; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2017 |
Hydroxytyrosol mildly improve cognitive function independent of APP processing in APP/PS1 mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognition; Diet, Mediterranean; Disease Models, Animal; Mice; Mice, Transgenic; Mitochondria; Olea; Oxidative Stress; Phenylethyl Alcohol | 2016 |
Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption.
Topics: Administration, Oral; Animals; Anterior Cruciate Ligament; Biflavonoids; Catechin; Cyclooxygenase 2; Diet; Dinoprostone; Disease Models, Animal; Female; Grape Seed Extract; Interleukin-1beta; Male; Mass Spectrometry; Matrix Metalloproteinase 13; Metabolome; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Olea; Osteoarthritis; Phenylethyl Alcohol; Proanthocyanidins; Rabbits; RNA, Messenger; Wounds and Injuries | 2016 |
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
Topics: Administration, Oral; Animals; Biomarkers; Caffeic Acids; CARD Signaling Adaptor Proteins; Disease Models, Animal; Gout; Inflammasomes; Liquid Crystals; Macrophages; Mice; Models, Molecular; Molecular Conformation; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylethyl Alcohol; Protein Binding; Uric Acid | 2016 |
Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation.
Topics: Animals; Biomarkers; Cardiovascular System; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Disease Models, Animal; Liver; Male; Metabolic Syndrome; Obesity; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2017 |
The LC-MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome.
Topics: Animals; Chromatography, Liquid; Disease Models, Animal; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolic Syndrome; Metabolome; Metabolomics; Olea; Phenylethyl Alcohol; Principal Component Analysis; Rats; Rats, Wistar | 2017 |
The effects of pollen, propolis, and caffeic acid phenethyl ester on tyrosine hydroxylase activity and total RNA levels in hypertensive rats caused by nitric oxide synthase inhibition: experimental, docking and molecular dynamic studies.
Topics: Adrenal Medulla; Animals; Caffeic Acids; Catalytic Domain; Catecholamines; Disease Models, Animal; Heart; Humans; Hypertension; Hypothalamus; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylethyl Alcohol; Pollen; Propolis; Rats; Tyrosine 3-Monooxygenase | 2018 |
Major phenolic compounds in olive oil modulate bone loss in an ovariectomy/inflammation experimental model.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Female; Flavonoids; Humans; Inflammation; Olive Oil; Osteoporosis; Ovariectomy; Phenols; Phenylethyl Alcohol; Plant Oils; Polyphenols; Random Allocation; Rats; Rats, Wistar | 2008 |
Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Fibrosis; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Humans; Longevity; Male; Myocardial Infarction; Myocytes, Cardiac; Phenylethyl Alcohol; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Sirtuin 1; Sirtuins; Survival | 2008 |
Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling.
Topics: Animals; Atherosclerosis; Caffeic Acids; Cell Adhesion; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Inflammation; Male; Mice; Monocytes; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phenylethyl Alcohol; Receptors, LDL; Rosiglitazone; Thiazolidinediones; Zinc | 2008 |
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats.
Topics: Adenosine Deaminase; Administration, Oral; Animals; Antioxidants; Antitubercular Agents; Caffeic Acids; Disease Models, Animal; Drinking; Drug Therapy, Combination; Erythrocytes; Injections, Intraperitoneal; Isoniazid; Male; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Purines; Rats; Rats, Wistar; Thioglycolates; Thiophenes; Xanthine Oxidase | 2008 |
Gingival vascular damage in atherosclerotic rabbits: hydroxytyrosol and squalene benefits.
Topics: Animals; Antioxidants; Arteries; Atherosclerosis; Collagen; Diet, Atherogenic; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Fibrosis; Gingiva; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mouth Mucosa; Olive Oil; Periodontal Diseases; Phenylethyl Alcohol; Plant Oils; Rabbits; Squalene; Ubiquinone | 2009 |
Therapeutic effect of caffeic acid phenethyl ester on cerulein-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Caffeic Acids; Ceruletide; Cytotoxins; Disease Models, Animal; Edema; Leukocyte Count; Lipase; Male; Pancreas; Pancreatitis; Phenylethyl Alcohol; Rats; Rats, Wistar; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Cyclosporine; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Kidney Diseases; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2009 |
Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats.
Topics: Animals; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Dietary Fats; Disease Models, Animal; Flavonoids; Glucose Intolerance; Heart; Hypertension; Inflammation; Liver; Male; Metabolic Syndrome; Myocardium; Obesity; Olea; Oxidative Stress; Phenols; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Plant Leaves; Polyphenols; Rats; Rats, Wistar | 2010 |
The effects of caffeic acid phenethyl ester and melatonin on age-related vascular remodeling and cardiac damage.
Topics: Aging; Animals; Antioxidants; Aorta; Caffeic Acids; Catalase; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Assays; Glutathione; Heart; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Mitochondria; Myocardium; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2011 |
Caffeic acid phenethyl ester protects against oxidative stress-related renal dysfunction in rats treated with cyclosporin A.
Topics: Acute Kidney Injury; Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Caffeic Acids; Creatinine; Cyclosporine; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding Behavior; Glutathione; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase | 2011 |
[Antioxidant and cardioprotective effects of N-tyrosol in myocardial ischemia with reperfusion in rats].
Topics: Animals; Antioxidants; Cardiotonic Agents; Coronary Vessels; Disease Models, Animal; Electrocardiography; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2010 |
Protective effects of caffeic acid phenethyl ester (CAPE) on intestinal damage in necrotizing enterocolitis.
Topics: Administration, Oral; Animals; Animals, Newborn; Apoptosis; Caffeic Acids; Caspase 9; Cell Count; Disease Models, Animal; Enterocolitis, Necrotizing; Ileum; Immunohistochemistry; In Situ Nick-End Labeling; NF-kappa B; Oxidative Stress; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Treatment Outcome; Xanthine Oxidase | 2011 |
Stilbenes and tyrosol as target compounds in the assessment of antioxidant and hypolipidemic activity of Vitis vinifera red wines from southern Brazil.
Topics: Animals; Antioxidants; Brazil; Disease Models, Animal; Humans; Hyperlipidemias; Hypolipidemic Agents; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylethyl Alcohol; Stilbenes; Vitis; Wine | 2011 |
Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model.
Topics: Administration, Oral; Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Glutathione; Huntington Disease; Injections, Intraperitoneal; Lipid Peroxidation; Male; Nitro Compounds; Olive Oil; Oxidative Stress; Phenylethyl Alcohol; Plant Oils; Propionates; Rats; Rats, Wistar; Succinate Dehydrogenase | 2011 |
In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice.
Topics: Animals; Antioxidants; Buthionine Sulfoximine; Catalase; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclophosphamide; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Industrial Waste; Lipid Peroxidation; Male; Mass Spectrometry; Mice; Olea; Phenylethyl Alcohol; Plant Extracts; Urinary Bladder; Urinary Bladder Diseases | 2011 |
Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Colitis, Ulcerative; Colon; Cyclooxygenase 2; Cytokines; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Female; Food, Fortified; Intestinal Mucosa; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Olive Oil; Phenylethyl Alcohol; Plant Oils; Random Allocation | 2012 |
Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro.
Topics: Animals; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Brain Ischemia; Cell Survival; Cerebral Cortex; Disease Models, Animal; Drug Administration Schedule; Galactosides; Glucosides; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Oxidants; Phenols; Phenylethyl Alcohol; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury | 2012 |
Caffeic Acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Caffeic Acids; Disease Models, Animal; Fluorescent Antibody Technique; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Recovery of Function | 2012 |
Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeic Acids; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Neuroprotective Agents; Phenylethyl Alcohol; Survival Rate; Treatment Outcome | 2012 |
Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor.
Topics: Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Caffeic Acids; Disease Models, Animal; Dopaminergic Neurons; Enzyme Induction; Heme Oxygenase-1; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide; Parkinsonian Disorders; Phenylethyl Alcohol; Rats; Rats, Wistar; Substantia Nigra | 2012 |
Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Caffeic Acids; Carcinogenicity Tests; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B1; Cytochromes; Diethylnitrosamine; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Phenylethyl Alcohol; Proadifen; Rats; Rats, Inbred F344; Steroid Hydroxylases | 2012 |
Alperujo extract, hydroxytyrosol, and 3,4-dihydroxyphenylglycol are bioavailable and have antioxidant properties in vitamin E-deficient rats--a proteomics and network analysis approach.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Anticholesteremic Agents; Antioxidants; Diet; Dietary Supplements; Disease Models, Animal; Food-Processing Industry; Fruit; Hypolipidemic Agents; Industrial Waste; Intestinal Absorption; Liver; Male; Methoxyhydroxyphenylglycol; Mitochondrial Proteins; Olea; Oxidative Stress; Phenylethyl Alcohol; Plant Extracts; Random Allocation; Rats; Vitamin E Deficiency | 2012 |
Caffeic acid phenethyl ester effects in the kidney during ischemia and reperfusion in rats anesthetized with isoflurane.
Topics: Anesthetics, Inhalation; Animals; Biomarkers; Caffeic Acids; Creatinine; Disease Models, Animal; Isoflurane; Kidney; Male; Necrosis; Phenylethyl Alcohol; Rats; Rats, Wistar; Reperfusion Injury; Time Factors | 2012 |
Caffeic acid phenethyl ester protects kidneys against acetylsalicylic acid toxicity in rats.
Topics: Acute Kidney Injury; Animals; Aspirin; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Kidney; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2012 |
Comparative analysis of the protective effects of caffeic acid phenethyl ester (CAPE) on pulmonary contusion lung oxidative stress and serum copper and zinc levels in experimental rat model.
Topics: Analysis of Variance; Animals; Blood Gas Analysis; Caffeic Acids; Catalase; Contusions; Copper; Disease Models, Animal; Humans; Lung; Male; Malondialdehyde; Oxidative Stress; Phenylethyl Alcohol; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Zinc | 2013 |
Effects of caffeic acid phenethyl ester on anastomotic healing in secondary peritonitis.
Topics: Anastomosis, Surgical; Animals; Caffeic Acids; Colon; Disease Models, Animal; Glutathione; Hydroxyproline; Male; Malondialdehyde; Peritonitis; Peroxidase; Phenylethyl Alcohol; Pressure; Rats; Rats, Wistar; Stress, Mechanical; Superoxide Dismutase; Wound Healing | 2012 |
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cell Line; Chromatography, Gas; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Humans; Inflammation; Interferon Regulatory Factor-3; Lipopolysaccharides; Lymphocyte Antigen 96; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Signal Transduction; Tandem Mass Spectrometry; Toll-Like Receptor 4 | 2013 |
Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats.
Topics: Adrenergic Agents; Animals; Antioxidants; Caffeic Acids; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Free Radical Scavengers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenylethyl Alcohol; Rats; Rats, Wistar | 2013 |
Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Drug Carriers; Hydrocortisone; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Skin Absorption | 2013 |
The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion.
Topics: Animals; Caffeic Acids; Catalase; Disease Models, Animal; Glutathione Peroxidase; Male; Peroxidase; Phenylethyl Alcohol; Protective Agents; Rats; Reperfusion Injury; Spermatic Cord Torsion; Superoxide Dismutase; Testis; Thiobarbituric Acid Reactive Substances | 2002 |
Effect of caffeic acid phenethyl ester on cartilage in experimental osteoarthritis.
Topics: Animals; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Caffeic Acids; Cartilage, Articular; Disease Models, Animal; Disease Progression; Extracellular Matrix; Hindlimb; Injections, Intra-Articular; NF-kappa B; Osteoarthritis, Knee; Phenylethyl Alcohol; Proteoglycans; Rabbits | 2002 |
Caffeic acid phenethyl ester (CAPE) prevents inflammatory stress in organotypic hippocampal slice cultures.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Caenorhabditis elegans Proteins; Caffeic Acids; Cell Nucleus; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Hippocampus; Immunohistochemistry; Inflammation; Interferon-gamma; Lipopolysaccharides; NF-kappa B; Nitrites; Organ Culture Techniques; Phenylethyl Alcohol; Rats; Rats, Wistar; Stress, Physiological; Tumor Necrosis Factor-alpha | 2003 |
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Homovanillic Acid; Immunohistochemistry; Male; Neurons; Parkinson Disease; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2003 |
Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay.
Topics: Animals; Blotting, Western; Caffeic Acids; Carcinoma, Hepatocellular; Cell Nucleus; Disease Models, Animal; Disease Progression; gamma-Glutamyltransferase; Gene Expression Regulation; Glutathione S-Transferase pi; Glutathione Transferase; Humans; I-kappa B Proteins; Isoenzymes; Liver Neoplasms, Experimental; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylethyl Alcohol; Precancerous Conditions; Protein Transport; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats.
Topics: Animals; Biomarkers; Brain; Caffeic Acids; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Oxidative Stress; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Wistar; Spinal Cord | 2004 |
Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats.
Topics: Analysis of Variance; Animals; Caffeic Acids; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Hearing Loss, Sensorineural; Otoacoustic Emissions, Spontaneous; Phenylethyl Alcohol; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2004 |
Caffeic acid phenethyl ester improves oxidative organ damage in rat model of thermal trauma.
Topics: Animals; Burns; Caffeic Acids; Disease Models, Animal; Injections, Intraperitoneal; Kidney Diseases; Lung Diseases; Male; Malondialdehyde; Multiple Organ Failure; Oxidoreductases; Phenylethyl Alcohol; Rats; Rats, Wistar; Treatment Outcome | 2004 |
[Xanthine oxidase inhibitory activity and hypouricemia effect of propolis in rats].
Topics: Animals; Anti-Infective Agents; Brazil; Caffeic Acids; China; Coumaric Acids; Disease Models, Animal; Flavonoids; Gout; Hyperuricemia; Male; Oxonic Acid; Phenylethyl Alcohol; Phenylpropionates; Propionates; Propolis; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2005 |
Effects of caffeic acid phenethyl ester on endotoxin-induced uveitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aqueous Humor; Caffeic Acids; Ciliary Body; Disease Models, Animal; Eye Proteins; Injections, Intraperitoneal; Iris; Lipopolysaccharides; Male; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Wistar; Salmonella typhimurium; Uveitis | 2005 |
In vivo effects of caffeic acid phenethyl ester on myocardial ischemia-reperfusion injury and apoptotic changes in rats.
Topics: Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Caffeic Acids; Cell Count; Coronary Disease; Creatine Kinase; Disease Models, Animal; Glutathione; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Nitric Oxide; Phenylethyl Alcohol; Rats; Rats, Wistar | 2005 |
Caffeic acid phenethyl ester ameliorates cerebral infarction in rats subjected to focal cerebral ischemia.
Topics: Animals; Antioxidants; Blood Flow Velocity; Brain; Brain Ischemia; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Phenylethyl Alcohol; Rats; Rats, Long-Evans; Reperfusion Injury | 2006 |
Role of vagal activity on bradicardic and hypotensive effects of caffeic acid phenethyl ester (CAPE).
Topics: Animals; Antihypertensive Agents; Atropine; Blood Pressure; Bradycardia; Caffeic Acids; Disease Models, Animal; Male; Muscarinic Antagonists; Parasympathetic Nervous System; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Vagotomy; Vagus Nerve | 2005 |
Black Lucques olives prevented bone loss caused by ovariectomy and talc granulomatosis in rats.
Topics: Animals; Antioxidants; Body Weight; Bone Density; Calcium; Disease Models, Animal; Female; Fruit; Humans; Inflammation; Olea; Organ Size; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Talc; Uterus; Vitamin E | 2007 |
Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Caffeic Acids; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Inflammation Mediators; Ischemic Attack, Transient; Male; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2007 |
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply | 2007 |
Effect of caffeic acid phenethyl ester on the regression of endometrial explants in an experimental rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Caffeic Acids; Catalase; Cyclooxygenase 2; Disease Models, Animal; Endometriosis; Endometrium; Female; Lipid Peroxidation; Malondialdehyde; Phenylethyl Alcohol; Rats; Rats, Wistar; Statistics, Nonparametric; Superoxide Dismutase; Transplantation, Autologous; Uterus | 2007 |
Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Caffeic Acids; Disease Models, Animal; Female; Histamine Release; Immunoglobulin E; Mice; Mice, Inbred ICR; NF-kappa B; Ovalbumin; Phenylethyl Alcohol; Tumor Necrosis Factor-alpha | 2008 |
Caffeic acid phenethyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Glutathione; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Reactive Oxygen Species; Skin; Superoxide Dismutase; Wound Healing | 2007 |
Effects of caffeic acid phenethyl ester on pancreatitis in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Bacterial Translocation; Bronchoalveolar Lavage Fluid; Caffeic Acids; Detergents; Disease Models, Animal; Glycodeoxycholic Acid; L-Lactate Dehydrogenase; Lung; Male; Malondialdehyde; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2008 |
Comparative study of Rhodiola preparations on behavioral despair of rats.
Topics: Administration, Oral; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Depression; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Glucosides; Male; Molecular Structure; Phenols; Phenylethyl Alcohol; Piper nigrum; Plant Preparations; Plant Roots; Rats; Rats, Wistar; Rhodiola; Stress, Physiological | 2008 |
In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats.
Topics: Animals; Antioxidants; Aorta, Abdominal; Cyclosporine; Disease Models, Animal; Ethidium; Gene Expression; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glutathione; Heme Oxygenase-1; Immunosuppressive Agents; Kidney Glomerulus; Lipid Peroxidation; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA; Thiobarbituric Acid Reactive Substances; Treatment Outcome | 2008 |
Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Caffeic Acids; Cell Count; Cytokines; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Peroxides; Phenylethyl Alcohol; Respiratory Hypersensitivity | 2008 |
The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits.
Topics: Animals; Antioxidants; Caffeic Acids; Catalase; Disease Models, Animal; Drug Therapy, Combination; Injections, Intraperitoneal; Malondialdehyde; Methylprednisolone; Movement; Neuroprotective Agents; NF-kappa B; Phenylethyl Alcohol; Rabbits; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Superoxide Dismutase | 1999 |
Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats.
Topics: Animals; Apoptosis; Arthritis; Caffeic Acids; Cells, Cultured; Colitis; Colon; Cytokines; Disease Models, Animal; Female; Humans; NF-kappa B; Peptidoglycan; Phenylethyl Alcohol; Rats; Rats, Inbred Lew | 2001 |